GSI treatment of HCC1599 xenografts likewise demonstrated transient and limited tumor growth control, while SOX2 expression rendered tumor cells insensitive to NOTCH inhibition, similar to iSOX2 MB157 xenografts. The gene discussed is SOX2; the disease is neoplasm.